DennisAWigleMD

Thoracic Surgery • Rochester, MN

Assistant Professor, Surgery, Mayo Medical School

Join to view full profile

Dr. Wigle is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wigle's full profile

Already have an account?

Office
200 1st St Sw
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

University of Toronto Faculty of MedicineClass of 1997

Certifications & Licensure

AZ State Medical License 2019 - 2025
MN State Medical License 2006 - 2025

Awards, Honors, & Recognition

Fellow (FACS) American College of Surgeons

Clinical Trials

Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer Start of enrollment: 2011 Apr 01
Terminated
Phase 2
Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients Non-Small Lung Cancer Start of enrollment: 2012 May 01
Terminated
Phase 2
Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer Start of enrollment: 2012 Oct 01
Terminated
Phase 2
Validation of the MiCK Assay Start of enrollment: 2012 Jun 01
Terminated
A Phase I Study of iPS Cell Generation From Patients With COPD Start of enrollment: 2009 Sep 01
Completed
Not Applicable
Treatment of Multifocal Lung Adenocarcinoma Start of enrollment: 2013 Oct 01
Active, not recruiting
Not Applicable
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma Start of enrollment: 2015 Aug 01
Recruiting
Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma Start of enrollment: 2015 Nov 01
Recruiting
Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma Start of enrollment: 2016 Mar 18
Recruiting
Staging Procedures to Diagnose Malignant Pleural Mesothelioma Start of enrollment: 2016 Mar 14
Recruiting
Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence Start of enrollment: 2017 Oct 01
Terminated
Progenitor Cells in Human Esophagus Start of enrollment: 2017 Jun 29
Completed
Join now to see all

Publications & Presentations

PubMed

15 citations
Clinical biomarkers of pulmonary carcinoid tumors in never smokers via profiling miRNA and target mRNA
Bo Deng, Julian R. Molina, Marie Christine Aubry, Zhifu Sun, Liang Wang
Cell & Bioscience. 2014-07-09
27 citations
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction.
Mojun Zhu, Chunhua Chen, Nathan R Foster, Christopher Hartley, Taofic Mounajjed
Clinical Cancer Research. 2022-07-15
13 citations
The course of achalasia one to four decades after initial treatment.
Tarek Sawas, Karthik Ravi, Debra M. Geno, Felicity Enders, Katrina Pierce
Alimentary Pharmacology & Therapeutics. 2017-02-01

Lectures

Mayo Clinic General Thoracic Surgery Symposium
Mayo School of Continuous Professional Development, Rochester, Minnesota - 5/3/2013

Press Mentions

Salvage Lung Resection After Immunotherapy in Lung Cancer Is Feasible and SafeMay 6th, 2023
Biostage Hires David Green as Chief Executive OfficerNovember 30th, 2021
Why You Can't Shake Pandemic Fatigue — and What to Do About ItAugust 10th, 2021
Join now to see all